期刊文献+

伴恶性高血压IgA肾病的临床病理特征及其与肾血管病变的相关性 被引量:16

Clinicopathological features of IgA nephropathy associated with malignant hypertension and their correlation to renal vascular lesions
原文传递
导出
摘要 目的分析伴恶性高血压IgA肾病(IgAN—MHT)的临床病理特征并探讨其与肾血管病变的相关性。方法从我科1997年4月至2007年5月间肾活检确诊的2000例原发性IgA肾病中筛选出29例IgAN.MHT患者,收集其临床、病理及预后资料。半定量分析肾小球、肾小管间质及血管(肾内微动脉、小动脉)的病理改变,包括436条入球动脉、124条小叶间动脉及5条弓形动脉。分析血管病变与肾脏病理改变、临床指标及预后的相关性。终点事件为基线Scr水平增加1倍或终末期肾病。结果原发性IgAN中MHT发生率约为1.5%。IgAN.MHT患者的临床表现主要为肾功能不全(100%)、高尿酸血症(62.7%)、高三酰甘油血症(51.7%),尿蛋白量(24h)平均为2.8g。常见肾脏病理改变为中度系膜细胞增殖、重度肾小球硬化、重度间质炎细胞浸润、重度肾小管萎缩及间质纤维化。IgAN—MHT患者的肾内小动脉(弓形动脉和小叶间动脉)及微动脉(入球动脉)均可受累。常见肾内血管病变特点为动脉闭塞、动脉中膜增厚、增生性动脉内膜炎(洋葱皮样改变、黏液样变性)、血管壁透明样变性,其中以肾内动脉闭塞为主(86.2%)。微动脉病变程度与年龄、总蛋白水平呈负相关;血管闭塞程度与尿酸水平呈正相关。平均随访21.1个月(1~84个月),14例患者达到终点。肾内微动脉病变是IgAN—MHT患者预后不良的主要危险因素(RR=10.21,95%CI=1.16~89.67)。结论IgAN—MHT的主要临床特点是肾功能不全;主要病理特征是以动脉闭塞为主的微动脉病变。微动脉病变是IgAN—MHT患者预后不良的主要危险因素。 Objective To explore the clinicopathological features of IgA nephrolpathy associated with malignant hypertension (IgAN-MHT) and to analyze their correlation with renal vascular lesions. Methods Twenty-nine patients of IgAN-MHT were screened from 2000 biopsy-proven cases with primary IgA nephropathy (IgAN) in our department from April 1997 to May 2007. Data of clinicopathology and follow-up of these 29 patients were collected. Semiquantitative analysis was performed to evaluate the pathological changes. Inner lumen, outer lumen, intimal thickness, tunica media-to-internal lumen ratio of 436 arterioles, 124 interlobular arteries and 5 areuate arteries were measured. The primary endpoint was the composite of a doubling of serum creatinine level and ESRD. Correlations of renal vascular lesions with clinical manifestation, pathological change and prognosis were examined by Spearman and Cox methods. Results 1.5% of all the IgAN patients presented malignant hypertension. The common clinical features were renal failure (100%), hyperuricacidemia (62.7%) and hypertriglyceridemia (51.7%). The average amount of urine protein excretion was 2.8 g/d. The common pathological changes were moderate mesangial proliferation, severe global sclerosis, severe interstitial inflammation and severe interstitial- tubular fibrosis. The small arteries (arcuate arteries and interlobular arteries) and arterioles (afferent arterioles) were both involved in IgAN-MHT. The characteristic lesions of intrarenal arteries included vascular occlusion, media thickening, proliferative endarteritis (onionskin lesion, musculomucoid intimal hyperplasia), hyaline arteriosclerosis, but mainly vascular occlusion (86.2%). The arteriole lesion was negatively correlated with age and total protein level; vascular occlusion was positively correlated with uric acid level. The average follow-up period was 21.1 months. Forteen patients reached the endpoint. The arteriole lesion was the main independent risk factor for the progressio
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第6期392-397,共6页 Chinese Journal of Nephrology
基金 国家自然科学基金重点项目(30630033)
关键词 肾小球肾炎 IGA 高血压 恶性 病理学 临床 动脉 预后 Glomerulonephritis, lgA Hypertension, malignant Pathology, clinical Arteries Prognosis
  • 相关文献

参考文献8

  • 1Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol, 1998,9:133- 142. 被引量:1
  • 2Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol, 1998,49:1-8. 被引量:1
  • 3Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol, 2008,28:1-7. 被引量:1
  • 4陈香美,谢院生.重视延缓IgA肾病进展的基础和临床研究[J].中华肾脏病杂志,2004,20(4):235-237. 被引量:155
  • 5Wu J, Chen X, Xie Y, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant, 2005,20:719-727. 被引量:1
  • 6Ikee R, Kobayashi S, Saigusa T, et al. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy. Hypertens Res, 2006, 29:15-22. 被引量:1
  • 7邱强,陈香美,谢院生,魏日胞,吴镝,蔡广研,刘述文.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6):329-331. 被引量:43
  • 8Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol, 2002,13:2888-2897. 被引量:1

二级参考文献10

  • 1陈香美,谢院生.重视延缓IgA肾病进展的基础和临床研究[J].中华肾脏病杂志,2004,20(4):235-237. 被引量:155
  • 2Syrjanen J,Mustonen J,Pasternack A.Hypertrigly ceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant,2000,15(1):34-42. 被引量:1
  • 3Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension,2003,41(6):1183-1190. 被引量:1
  • 4Wu J,Chen X, Xie Y,et al.Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant,2005,20(4):719-727. 被引量:1
  • 5Katafuchi R, Kiyoshi Y,Oh Y,et al.Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol,1998,49(1):1-8. 被引量:1
  • 6Johnson RJ,Schreiner GF.The role of acquired tubuloterstial disease in the paphogenesis of salt dependent hypertension. Kidney Int,1997,52(5):1169-1179. 被引量:1
  • 7Tinahones JF,Perez-Lindon G,C-Soriguer FJ,et al.Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab,1997,82(4):1188-1191. 被引量:1
  • 8Kang DH,Nakagawa T,Feng L,et al.A role for uric acid in the progression of renal disease.J Am Soc Nephrol,2002,13(12):2888-2897. 被引量:1
  • 9Sanchez-Lozada LG,Tapia E,Santamaria J,et al.Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.Kidney Int,2005,67(1):237-247. 被引量:1
  • 10张燕平,陈香美,庄永泽,危成筠,石晓云.肾小管间质损害在IgA肾病中的临床意义[J].中华内科杂志,2001,40(9):613-617. 被引量:94

共引文献192

同被引文献176

引证文献16

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部